A tolerability and safety analysis of adding granulocyte-macrophage colony-stimulating factor to local radiotherapy in a case series of seven patients with thoracic cancer | Zendy

BiCheng Wang | Zendy; Pengcheng Li | Zendy; BoHua Kuang | Zendy; Zhanjie Zhang | Zendy; BoYa Xiao | Zendy; GuoHe Lin | Zendy; Quentin Liu | Zendy

Open Access

A tolerability and safety analysis of adding granulocyte-macrophage colony-stimulating factor to local radiotherapy in a case series of seven patients with thoracic cancer

Author(s) -

BiCheng Wang,

Pengcheng Li,

BoHua Kuang,

Zhanjie Zhang,

BoYa Xiao,

GuoHe Lin,

Quentin Liu

Publication year - 2021

Publication title -

annals of palliative medicine

Language(s) - English

Resource type - Journals

eISSN - 2224-5839

pISSN - 2224-5820

DOI - 10.21037/apm-20-2248

Subject(s) - medicine , radiation therapy , tolerability , adverse effect , lung cancer , cancer , granulocyte colony stimulating factor , oncology , gastroenterology , surgery , chemotherapy

Granulocyte-macrophage colony-stimulating factor (GM-CSF) has been demonstrated to improve the anti-cancer effects in combination with radiotherapy. However, the tolerability and safety of adding GM-CSF to radiotherapy in thoracic cancer patients need to be further explored.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research